Health ❯Obesity ❯Weight Loss

Medications

Zepbound GLP-1 Drugs Ozempic NHS NHS Services Medicare and Medicaid Coverage Wegovy and Ozempic Semaglutides GLP-1 Receptor Agonists GLP-1RA Benefits Public Opinion Diabetes Treatment GLP-1 Agonists Semaglutide Tirzepatide Side Effects Mounjaro Ozempic and Wegovy

Poll Shows Americans Divided Over Weight-Loss Drugs for Obesity Treatment

Medicare to Cover Eli Lilly’s Zepbound for Sleep Apnea Treatment

GLP-1 Drugs Show Promise Beyond Diabetes and Obesity but Raise Cost and Ethical Concerns

FDA Approves Zepbound as First Drug Treatment for Sleep Apnea

U.S. Obesity Rates Decline for First Time in Over a Decade

UK Government Trials Weight-Loss Jabs to Tackle Unemployment

Novo Nordisk's Obesity Pill Shows Modest Results, Stocks Drop

New Weight Loss Drug Shows 'Remarkable' Results in Clinical Trials